Expertise in
2
conditions

Dr. Jason M. Glover

Hematology | Oncology
Randall Children's Cancer And Blood Disorders Program-A Department Of Legacy Emanuel Medical Center
2801 N Gantenbein Ave # 3, 
Portland, OR 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Expertise in
2
conditions
Randall Children's Cancer And Blood Disorders Program-A Department Of Legacy Emanuel Medical Center
2801 N Gantenbein Ave # 3, 
Portland, OR 

Overview

Jason Glover is a Hematologist and an Oncologist practicing medicine in Portland, Oregon.

Dr. Glover is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Hereditary Spherocytosis, Acute Lymphoblastic Leukemia (ALL), Febrile Neutropenia, Neuroblastoma, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 3 clinical trials. Dr. Glover is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Pediatrics in VA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Prominence Health
  • EPO
  • PPO
Regence
  • EPO
  • PPO
Samaritan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
View 14 Less Insurance Carriers -

Locations

Randall Children's Cancer And Blood Disorders Program-A Department Of Legacy Emanuel Medical Center
2801 N Gantenbein Ave # 3, Portland, OR 97227

Additional Areas of Focus

Dr. Glover has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Newly Diagnosed High-Risk Neuroblastoma
A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Newly Diagnosed High-Risk Neuroblastoma
Enrollment Status: Recruiting
Publish Date: September 04, 2026
Intervention Type: Drug
Study Drugs: Ceritinib, Dasatinib, Sorafenib, Vorinostat, DFMO
Study Phase: Phase 2
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2026
Intervention Type: Drug
Study Drug: Difluoromethylornithine (DFMO)
Study Phase: Phase 2
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Enrollment Status: Completed
Publish Date: November 03, 2025
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trial

11 Total Publications

Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart Failure.
Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart Failure.
Journal: Journal of the American College of Cardiology
Published: April 24, 2024
Similar Doctors
Expertise in
8
conditions
Dr. Hagen F. Kennecke
Hematology | Oncology
Expertise in
8
conditions
Dr. Hagen F. Kennecke
Hematology | Oncology
Referral may be required

Providence Cancer Institute Franz Clinic

4805 NE Glisan St Ste 11N-1, 
Portland, OR 
 (3.8 miles away)
503-215-5696
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Hagen Kennecke is a Hematologist and an Oncologist practicing medicine in Portland, Oregon. Dr. Kennecke is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Carcinoid Syndrome. Dr. Kennecke is currently accepting new patients.

Expertise in
24
conditions
Expertise in
24
conditions
Referral may be required

OHSU Knight Cancer Institute South Waterfront

3485 S Bond Ave, 
Portland, OR 
 (3.1 miles away)
503-494-6594
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lara Davis is an Oncologist practicing medicine in Portland, Oregon. Dr. Davis is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Rhabdomyosarcoma Embryonal, and Retroperitoneal Liposarcoma. Dr. Davis is currently accepting new patients.

Expertise in
27
conditions
Expertise in
27
conditions
Referral may be required

University Andrology Lab LLC

3303 S Bond Ave, 
Portland, OR 
 (3.1 miles away)
503-494-8311
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Richard Maziarz is a Hematologist practicing medicine in Portland, Oregon. Dr. Maziarz is highly rated in 27 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Maziarz is currently accepting new patients.

Frequently Asked Questions about Dr. Jason M. Glover

How do I make an appointment with Dr. Jason M. Glover?

You can book an appointment with Dr. Jason M. Glover by calling their office at 503-276-9300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jason M. Glover a top-rated expert for Hereditary Spherocytosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jason M. Glover is classified as an Advanced expert for Hereditary Spherocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jason M. Glover specialize in?

While Dr. Jason M. Glover is a Hematology, they have specific expertise in Hereditary Spherocytosis, Acute Lymphoblastic Leukemia (ALL), and Febrile Neutropenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Jason M. Glover participate in research or clinical trials?

Yes. Dr. Jason M. Glover has published 11 articles and abstracts on conditions like Hereditary Spherocytosis. You can view a list of Dr. Jason M. Glover's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jason M. Glover accept my insurance?

Dr. Jason M. Glover accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 503-276-9300 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Glover's expertise for a condition
ConditionClose
      View All 61 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile